Sigilon Therapeutics Inc. (SGTX)
NASDAQ: SGTX
· Real-Time Price · USD
22.47
-0.59 (-2.56%)
At close: Aug 10, 2023, 10:00 PM
Sigilon Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 17.65M | 14.64M | 12.94M | 12.29M | 9.98M | 9.81M | 9.6M | 11.37M | 13.62M | 12.87M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 17.65M | 14.64M | 12.94M | 12.29M | 9.98M | 9.81M | 9.6M | 11.37M | 13.62M | 12.87M |
Operating Income | -30.84M | -37.44M | -43.67M | -53.23M | -64.55M | -70.55M | -75.64M | -72.43M | -65.25M | -58.53M |
Interest Income | 1.61M | 1.36M | 946K | 588K | 344K | 237K | 259K | 257K | 231K | 195K |
Pretax Income | -30.24M | -37.08M | -43.56M | -54.62M | -66.11M | -72.2M | -77.31M | -74.75M | -67.79M | -60.85M |
Net Income | -29.57M | -36.72M | -43.07M | -55.18M | -66.42M | -72.2M | -77.31M | -74.75M | -67.79M | -60.85M |
Selling & General & Admin | 19.12M | 18.28M | 18.98M | 19.05M | 19.7M | 19.65M | 20.17M | 19.08M | 17.37M | 15.2M |
Research & Development | 29.37M | 33.8M | 37.63M | 46.46M | 54.83M | 60.7M | 65.07M | 64.72M | 61.5M | 56.2M |
Other Expenses | 143K | 117K | 158K | 166K | 134K | 104K | 55K | 5K | -41K | -77K |
Operating Expenses | 48.49M | 52.07M | 56.61M | 65.52M | 74.53M | 80.35M | 85.24M | 83.8M | 78.87M | 71.4M |
Interest Expense | 2.18M | 2.41M | 2.29M | 2.15M | 2.04M | 1.99M | 1.99M | 1.99M | 1.78M | 1.48M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 48.49M | 52.07M | 56.61M | 65.52M | 74.53M | 80.35M | 85.24M | 83.8M | 78.87M | 71.4M |
Income Tax Expense | -666K | -356K | -487K | 558K | 835K | 1.04M | 1.53M | 1.53M | 1M | 484K |
Shares Outstanding (Basic) | 32.47M | 32.47M | 32.46M | 32.4M | 32.4M | 2.49M | 2.46M | 2.47M | 2.43M | 2.42M |
Shares Outstanding (Diluted) | 32.47M | 32.47M | 32.46M | 32.4M | 32.4M | 2.49M | 2.46M | 2.47M | 2.43M | 2.42M |
EPS (Basic) | -0.91 | -1.13 | -6.47 | -13.52 | -21.41 | -29.38 | -31.64 | -30.69 | -28.48 | -28.39 |
EPS (Diluted) | -0.91 | -1.13 | -6.47 | -13.52 | -21.41 | -29.38 | -31.64 | -30.69 | -28.48 | -28.39 |
EBITDA | -26.85M | -33.72M | -40.32M | -51.53M | -63.13M | -69.32M | -74.51M | -71.35M | -64.33M | -57.74M |
EBIT | -28.06M | -34.67M | -41.27M | -52.48M | -63.63M | -69.34M | -74.06M | -71.04M | -64.46M | -58.08M |
Depreciation & Amortization | 3.47M | 3.71M | 3.23M | 1.84M | 1.47M | 1.19M | 1.12M | 1.04M | 954K | 899K |